ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,867Medicare Part D Prescriptions Filled, Including Refills

Rank: 302 out of 1171

$626K Total Retail Price of All Prescriptions

Rank: 129 out of 1171

386 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 6,356 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$91 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 334 312 1 1
AMLODIPINE BESYLATE 264 235 2 2
LEVOTHYROXINE SODIUM 217 189 3 4
OMEPRAZOLE 208 196 4 5
ZOLPIDEM TARTRATE 168 165 5 21
FUROSEMIDE 128 112 6 6
METOPROLOL SUCCINATE 119 119 7 17
METFORMIN HCL 113 107 8 7
AZITHROMYCIN 107 103 9 43
GABAPENTIN 106 103 10 16
CRESTOR 106 103 10 27
ATENOLOL 103 103 12 15
HYDROCHLOROTHIAZIDE 95 80 13 9
EXELON 91 91 14 164
SINGULAIR 87 87 15 78
RANITIDINE HCL 86 83 16 38
SERTRALINE HCL 85 74 17 23
NEXIUM 85 79 17 25
DIOVAN HCT 84 84 19 65
ADVAIR DISKUS 81 74 20 51
LOSARTAN-HYDROCHLOROTHIAZIDE 79 68 21 40
HYDROCODONE-ACETAMINOPHEN 79 72 S3 21 8
LANTUS 78 77 23 46
DIOVAN 73 73 24 32
GLYBURIDE 73 72 R 24 97
EVISTA 73 61 24 154
DESOXIMETASONE 72 61 27 400
DICYCLOMINE HCL 71 70 28 260
METOPROLOL TARTRATE 69 69 29 11
CARVEDILOL 68 59 30 20
PROAIR HFA 67 64 31 49
ATORVASTATIN CALCIUM 64 55 32 10
AMOXICILLIN 61 50 33 111
LISINOPRIL 59 50 34 3
IBUPROFEN 58 44 35 80
DICLOFENAC SODIUM 56 52 36 103
ENALAPRIL-HYDROCHLOROTHIAZIDE 56 51 36 359
JANUMET 55 51 38 233
CLOPIDOGREL 53 51 39 35
ALENDRONATE SODIUM 53 50 39 33
PLAVIX 52 49 41 55
TAMSULOSIN HCL 52 49 41 28
ENALAPRIL MALEATE 50 44 43 73
LEVOFLOXACIN 50 43 43 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.